Research

FDA panel recommends CBD medication for epilepsy

April 20, 2018
 

se E. Cavazos, M.D., Ph.D., professor of neurology and physiology at UT Health San Antonio and assistant dean of the institution’s M.D./Ph.D. program, reviewed clinical studies of the drug, which would be sold under the brand name Epidiolex.

Read more

Annual dental symposium features posters, talks, new mentor award

April 18, 2018
 

The symposium celebrates accomplishments in all areas of research, including education, public health, clinical sciences and basic sciences.

Read more


UT Health San Antonio launches brand campaign

April 16, 2018
 

The campaign seeks to inform consumers that the work of UT Health San Antonio improves the entire spectrum of health care.

Read more


Dr. Ramirez named a Komen Scholar for breast cancer research

April 9, 2018
 

Komen Scholars are an advisory group of distinguished leaders in breast cancer research and advocacy. Dr. Ramirez will also receive $600,000 for Latino breast cancer research.

Read more

Pancreatic cancer research method

Injecting gene cocktail into mouse pancreas leads to humanlike tumors

April 5, 2018
 

The groundbreaking technology could revolutionize studies of pancreatic cancer initiation and progression, and spur new drug development.

Read more



Researchers find link between congenital heart defects and adrenal gland cancer

March 29, 2018
 

Team led by Patricia Dahia, M.D., Ph.D., of UT Health San Antonio.

Read more